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Localization Matters: A Nuclear Targeting Two-Photon Absorption 
Iridium Complex Induced Intracellular Immigration and Dual-
damage in Photon Dynamic Therapy 
Xiaohe Tian ab* ‡, Yingzhong Zhu b ‡,  Mingzhu Zhang ab, Lei Luo c, Jieying Wu b, Hongping Zhou b, 
Lijuan Guan de, Giuseppe Battaglia de, Yupeng Tian bf * 
Dedicated to Professor Yupeng Tian for celebration of his 60th birthday. 
We present a two-photon (2P, 800nm) PDT cyclometalated Iridium 
(III) complex (Ir-Es) that targets intracellular nucleus, it is capable of 
imigrating sequentially from nucleus to mitochondria and inducing 
dual-damage under light exposure. It is suggest that with minor 
modification of complexes terminal moieties, their final 
intracellular destinations and PDT efficiency can significantly be 
impacted.  
Photodynamic therapy (PDT) has drawn increasing attention 
over the past decades and has been successfully applied in 
treatment of certain types of cancer.1 PDT is considered as a 
non-invasive treatment and relies on the use of combination of 
a photosensitizer (PS), light, and oxygen.2 Generally, an ideal PS 
should present non-toxicity in absence of light. When excited 
under the selected laser，it reacts with the molecular oxygen 
(3O2) at ground state, consequently, generating 1O2 and other 
reactive oxygen species (ROS),3 which are considered as the 
primary toxic species at subcellular organelles or vasculature 
damage.4 Although several PDT agents are clinically available, 
weak photostability, poor water solubility, high energy/shallow 
tissue penetration laser (excited from 400 to 700 nm) and 
excessed oxygen consuming still prevent their development.5 
Moreover, previous PDT agents including functionalized nano-
particles are restricted to damage in one subcellular organelle 
(e.g. mitochondria and endoplasmic reticulum),6 whereas 
nuclear or multi-organelle specific PSs are rarely existed. To 
tackle these barriers, two-photon (2P) PDT agents have been 
proposed to alter current PSs.6a, 7 Compared with traditional 
PDT agents, 2P-PDT agents apply low energy near-infrared laser 
as light source, which displays significant benefits including less 
photobleaching of PSs and deeper tissue penetration.8 
Luminescent cyclometalated Iridium (III) complexes with two-
photon absorption (2PA) behaviors have been widely 
investigated, particularly for their bio-application,9 their 
utilization on PDT induced cell death was also well discussed.10 
Their main merits can be concluded as follows: (i) High 
photostability allows continuous irradiation and real-time 
monitoring of intracellular trafficking. (ii) Long-lived triplet 
states result in long lifetime and provide possible reaction with 
oxygen to generate ROS. (iii) Large Stokes Shift can minimize the 
possible self-quenching effect even in high concentration. (iv) 
Compatibility with two-photon excitation achieves deeper 
tissue-penetration and excellent resolution.11  
 
Scheme 1. The molecular structure of Ir(III) complexes. 
In this work, we report terpyridine-based cyclometalated 
Iridium (III) complex that can be used as 2P-PDT agents and 
Iridium (III) is chosen as considering below. C-Ir metal bond, 
constructed by 2-phenyl pyridine, was used to stabilize the 
energy levels of the Ir complexes. Subsequently, the 
photophysical properties were tuned by using terpyridine 
derivatives, which used as bidentate ligand. Finally, terminal 
substitutes were modified to obtain different Ir(III) complexes 
to adjust their pull/push electronic capability and bio-affinity. 
Intriguingly, we found that complex Ir-Es could specifically 
target cell nucleus via intracellular microtubules dependent 
endocytosis and induced DNA binding. Subsequent two-photon 
irradiation triggered the immigration of Ir-Es from nucleus to 
mitochondria in living cells with efficient dual PDT damage, thus 
shedding light on the further practical utilization of Ir-Es as an 
anti-tumour agent. Compared with commercially available PS 
agent Chlorin e6 (Ce6, 660 nm),12 Ir-Es displayed considerable 
inhibition (2P: 808 nm) towards solid tumour growth in vivo in 
a mouse model. 
The detailed synthesis and characterization of Ir(III) complexes 
including Ir-Es, Ir-Me, Ir-Pn, Ir-Pc and Ir-Cz used in this study 
were stated in the Supporting information (Scheme S1, Fig. S1-
S5). As expected, these complexes displayed singlet and triplet 
metal-to-ligand charge transfer (MLCT) ranging from 350 nm to 
520 nm (Fig. S6 and Table S2),13 and the emission bands were 
located in range of 570 - 600 nm (shift > 25 nm, Fig. S6). These 
a. School of Life Science, Anhui University, Hefei 230039, P. R. China  
b. Department of Chemistry, Key Laboratory of Functional Inorganic Material 
Chemistry of Anhui Province, Anhui University, Hefei 230039, P. R. China 
c. College of Pharmaceutical Sciences, Southwest University, Chongqing 400716, 
China 
d. Department of Chemistry, University College London, London WC1H 0AJ, UK 
e. Department of Chemical Engineering, University College London, London WC1H 
0AJ, UK 
f. State Key Laboratory of Coordination Chemistry, Nanjing University, Nanjing 
210093, P. R. China 
* Correspondence: E-mail: xiaohe.t@ahu.edu.cn; yptian@ahu.edu.cn  
‡ These authors contributed equally to this work. 
Page 1 of 4 ChemComm
C
h
e
m
C
o
m
m
A
c
c
e
p
te
d
M
a
n
u
s
c
ri
p
t
Pu
bli
sh
ed
 on
 15
 Fe
bru
ary
 20
17
. D
ow
nlo
ad
ed
 by
 A
nh
ui 
Un
ive
rsi
ty 
on
 15
/02
/20
17
 14
:28
:58
. 
View Article Online
DOI: 10.1039/C6CC09470H
COMMUNICATION Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
five complexes displayed varied luminescent lifetimes and 
quantum yields, indicating tunable emission properties of Ir (III) 
complexes.14 The 2PA cross sections (σ) of the five Iridium 
complexes from 700-900 nm were shown in Fig. S7. The largest 
2PA cross-sections of Ir complexes were located around 800 ± 
30 nm with δ values between 60 - 110 GM.  
 
Fig. 1. (a) HepG2 cells toxicity data under dark and UV light 
condition (24-hrs, interval=6 hours, 5 minutes/time) for Ir-Es and 
Ir-Me obtained from the MTT assay; (b) The decrease of 
absorption of ADPA (100 μM dissolved in PBS mixed with 5 μM 
Ir-Es and Ir-Me, respectively) with laser exposure for 0, 0.5, 1, 5, 
10, 15 min.  
The impact of Iridium complexes treated cells under dark and 
irradiation condition was firstly evaluated by MTT assay. The cell 
viability of HepG2 (human liver cancer cell) (Fig. 1a and S8) as 
well as on non-cancerous HELF (human embryo liver fibroblast, 
Fig. S9) suggested that under dark incubation, Ir-Es displayed 
less invasive property (~85 %, 15 μM, 24 hours), whereas under 
UV irradiation a significant reduction in cell viability was 
detected. Compared with Ir-Me treated cells as showed in Fig. 
1a, it is apparent that Ir-Es (~4% viability) possess more potency 
of phototoxic effects under UV condition than Ir-Me complex 
(~35% viability). This difference was interesting since the 
capability of singlet-oxygen generation form Ir-Me and Ir-Es 
showed no difference (Fig. 1b and Fig. S10), which indicated a 
chemical based method by monitoring the deduction of 
absorption of ADPA (9,10-Anthracenedipropionic acid),5c with 
∆abs = 0.2755 (Ir-Es, 15min) and 0.2875 (Ir-Me, 15min), 
respectively. Considering the significant oxygen consumption 
required by Ce6, moderate ROS generation nature of Ir(III) 
complexes might have more advantages particularly against 
hypoxic solid tumour, which bears by an inadequate oxygen 
supply.15  
We therefore decided to evaluate the intracellular distribution 
of Ir-Es. The HepG2 cells were incubated with 5 μM complexes 
for 1 hour and MLCT (metal-to ligand charge transfer) emission 
and 2P confocal micrographs in living cells were successfully 
achieved (Fig. S11 and S12). It is notable that either from 
confocal images (Fig. 2a and 2b) or the single cell intensity 
profiles (Fig. S13), Ir-Es located in different subcellular 
compartment by contrast to the other Ir-complexes (Ir-Me, Ir-
Pn, Ir-Pc and Ir-Cz). Ir-Es dominantly located in nuclear region, 
while other Ir(III) complexes distributed only in cytosolic space. 
The precise location in subcellular organelles was further 
confirmed by colocolization experiments using nuclear stains 
Hoechst 33342 (Hoechst) and mitochondrial marker 
Mitotracker Far-Red (MT-FR) (Fig. 2a and 2b). The confocal 
micrographs (and 3D micrographs, Fig. S14) strongly suggested 
that Ir-Es targeted intracellular nucleus (Pearson Correlation 
Coefficient Rr = 0.8384); in contrast, Ir-Me as a representative 
for the other four complexes, showed much less overlapping 
with nucleus but strong overlap with mitochondria (Fig. S15). 
We speculated that the variation in cell uptake were due to 
different terminal moiety on Ir-Es and other Ir(III) complexes, 
consequently, leading to the disparate entry mechanism. 
Therefore, cell entry inhibition studies were performed (Fig. 
S16-S18) 16 and the intracellular intensity analysis suggested 
that Ir-Es cell entry could be considerably decreased by 
colchicine (microtubule-dependent endocytosis), a chemical 
could disrupt the polymerization of microtubules and further 
hinder endosomal trafficking; whereas the Ir-Me cell uptake 
was significantly reduced by several other inhibitors including 
choroquine (lysosomotropic agent), ammonia chioride 
(lysosomotropic agent) and chlorpromazine (clathrin-mediated 
endocytosis). As Ir-Es and Ir-Me shared the same backbone 
besides terminal substituent, we presumed that complexes’ 
ester (Ir-Es) or methyl (Ir-Me) terminal might trigger specific 
microtubules dependent endocytosis or clathrin-mediated 
endocytosis, subsequently the former rerouted to cell nucleus 
and the latter accumulated within mitochondria, respectively. 
Their energy dependent cell entry pathways were further 
confirmed by incubating Ir-Es and Ir-Me with pre-fixed cells (Fig. 
S19). Compare to in cellulo results, both Ir-Es and Ir-Me showed 
a generalized cytosolic staining with no mitochondrial and 
nuclear specificity.  
In addition to photoluminescence confocal microscopy, 
transmission electron microscopy (TEM) image of Ir-Es and Ir-
Me complexes was used to confirm cellular distribution owing 
to the scattering electron capability of transition metal complex 
specifically accumulated at subcellular compartments.17 HepG2 
cells stained with osmium tetroxide (OsO4) were used as 
control groups to show detailed information of intracellular 
membrane composition, such as nuclear membrane, vesicles 
and bilayer mitochondria structure (Fig. 2e, left). Compared to 
osmium tetroxide treated cells, Ir(III) complexes solely treated 
cells without OsO4  showed much weaker membrane contrast. 
However, Ir-Es treated cells presented reduced contrast in 
cytosolic regions, while significant greater contrast was 
detected in the nuclear space, suggesting that Ir-Es complex 
accumulated within cell nucleus (Fig. 2e, right). Ir-Me 
intracellular distribution (Fig. S20) displayed abundant cylinder-
like structures in cytosol, which were highly correspondent to 
mitochondria. Considering the singlet-oxygen generation and 
living cell staining results obtained from Ir-Es complex, the PDT 
on HepG2 cells was carried out. Ir-Me did not present significant 
cell damage after initial (30-times, 800 nm) laser irradiation (Fig. 
S21). Its analogue Ir(bpy) (Figure S2 and S4 for characterization) 
also indicated relatively lower PDT efficiency with mitochondrial 
staining (Fig, S22 and S23).  On the contrary, cells incubated 
with Ir-Es complex showed nuclear uptake and presented 
healthy morphology before light treatment (Fig. 3a). Once a 
smaller region was specifically selected (red line box) for laser 
irradiation (Fig. 3b), drastic morphology changes of cells could 
be clearly observed (Fig. 3c and 3d, black-dot box). 
 
Fig. 2. (a) and (b), HepG2 cells incubated with Ir-Es and co-
localized with Hoechst 33342 and Mitotraker Far-Red (MT-FR), 
scale bar= 20 μm. (c) TEM microscopy of HepG2 cells stained 
with osmium tetroxide (d) solely incubated with Ir-Es without 
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osmium tetroxide; Abbreviations: n = nucleus, mt = 
mitochondria. TEM scale bar= 5 μm. 
 
Fig. 3. (a) 2P confocal micrograph before and (b) after continued 
irradiation at selected region (red box); (c) and (d) DIC 
micrographs showed the morphology before and after 
irradiation; (e) Single cell Ir-Es intensity profile before and after 
irradiation. (f) Cell intensity from nuclear and cytosolic region 
analysis over time after 30 scans. (g) Time series micrographs 
from selected region. (h) Colocolization Ir-Es complex and MT-
FR after 2min continued 2P scanning. (i) TEM microscopy of 
HepG2 cells incubated with Ir-Es after UV light exposure. (j) Left: 
gray value intensity analysis showed Photocleavage effect of Ir-
Me and Ir-Es. Right: Photocleavage of pBR322 DNA using Ir-Me 
and Ir-Es under illuminated condition. (k) Molecular docking 
between selected DNA segment and Ir-Es and DAPI with (l) 
docking scores. (m) Schematic representation of proposed Ir-Es 
complex intracellular PDT mechanism. Abbreviations: 
n=nucleus, mt=mitochondria, mb= microtubulin, pm=plasma 
membrane, nm=nuclear membrane. Scale bar = 10μm. p < 
0.005. Error bars: SEM. 
It was noteworthy that during 30-time scanning, significant 
signals of Ir-Es immigrated from nuclear to cytosolic region and 
formed cylinder-like structure. The single cell intensity profile 
(Fig. 3e) clearly suggested that Ir-Es complex located in nuclear 
and cytosol before and after 800nm light treatment. Time-lapse 
micrographs (Fig. 3g, also refer to Fig. S movie-1 and S movie-2) 
indicated that Ir-Es complexes were gradually released from 
nuclear region and accumulated in cytosolic region upon laser 
irradiation (Fig. 3g), resulting in decreased fluorescence 
intensity of Ir-Es in nuclear and increased in cytosol, 
respectively (Fig. 3f). For comparison, the Ir-Es PDT effect under 
hypoxia condition was also performed with less cells damage 
and displayed no immigration (Fig. S24 and S25).  The binding 
property of Ir-Es after the initial scans was confirmed by 
colocolization experiments with MT-FR under confocal 
microscopy and inductively coupled plasma mass spectrometry 
(ICP-MS) (Fig. S26). Due to the cationic nature of Ir-Es, high 
overlapping between Ir-Es complex and Mitotracker Far Red 
(Fig. 3h) was clearly observed, this also proved by ICP-MS 
evaluation. Additionally, the PDT impact on cell bioactivity after 
irradiation under Ir-Es and Ir-Me treatments were also 
quantitatively confirmed by mitochondria activity and nuclear 
permeability using classic JC-118 labelling kit and ANNEXIN-V 
FITC/PI (propidium iodide) double staining19 kit, respectively. 
Both Ir-Es and Ir-Me treated cells showed significant 
mitochondrial damage after irradiation (Fig. S27) and emitted in 
green channel (λEx=488 nm, λEm=500-520 nm). Whereas 
extensive FITC/PI double positive signals after continued two-
photon treatment (800 nm, 180 s) demonstrated an effective 
PDT outcome (Fig. S28) that induced significant cell death and 
nucleus damage with permeable nuclear membrane; and 
relatively lower FITC and neglectable PI signal treated with Ir-
Me under the same condition suggested why it was the 
localization difference matters. These results were further 
strengthened by TEM micrographs. The cells here were 
incubated with Ir-Es and received 4 illuminations within two 
hours incubation (illumination=30 s, interval=30 min), as 
comparison the Ir-Me group was also added (Fig. S29). In order 
to highlight the intracellular structure and membrane damage, 
we performed the second fixation using OsO4 for 1 hour. 
Compared to previous untreated cells under TEM (Fig. 2e, left), 
it clearly showed that after UV irradiation, Ir-Es treated cells 
contained abundant vacuoles, an organelle that plays a major 
role in early autophagy, leading to apoptotic cell death20 (Fig. 3i, 
left). It had also clearly showed swollen mitochondria and 
misshapen nuclear structures in Ir-Es treated cells (Fig. 3i, right). 
In a good agreement with above confocal studies, the Ir-Es 
treated cells not only demonstrated considerable pre-
autophagosomal structures (PAS) in cytosolic region, but also 
displayed much less contrast in nuclear region with a certain 
degree of nucleus misshapen or damage (red star). The above 
results highly suggested that an effective double damage had 
been occurred in Ir-Es treated cell sequentially from nucleus to 
mitochondria under irradiation, which was in a good agreement 
with the initial MTT assay that Ir-Es displayed a much stronger 
phototoxic response. 
As Ir-Es located within nuclear in living cells, a model DNA was 
used to evaluate the capability of Ir-Es induced singlet-oxygen-
mediated damage under light irradiation in cell-free 
experiments. The supercoiled pBR322 DNA treated with 30 μM 
Ir-Es and Ir-Me followed by 10 min illumination and 1 hour 37 
oC incubation. Significant DNA cleavage was observed for Ir-Es 
treated group as the intensity of Lane-I (~2000 bp) was 
decreased and the intensity of Lane-II (~150 bp) was sharply 
increased (Fig. 3j). In contrast, at the same illuminated 
condition, Ir-Me complex with non-nuclear binding specificity 
showed much less DNA cleavage effect. The DNA cleavage 
effect of Ir-Es was confirmed via DNA binding experiments 
either in in vitro buffer solution (Fig. S30) and molecular 
modelling calculations using Discovery Studio Software (~9 fold 
stronger than DAPI, Fig. 3k and 3l, Fig. S31). 21 
Subsequently, on the basis of all of the results obtained above, 
we proposed a possible PDT mechanism (Fig. 3m): (1) Ir-Es with 
suitable positive charge, lipophilicity and ligand targeting 
moiety readily triggers microtubules dependent endocytosis 
across the plasma membrane and nuclear membrane, 
colocolized with DNA-riched chromatin or chromosomes. (2) 
Generated ROS induce DNA cleavage under two-photon 
irradiation and Ir-Es were released from nucleus, penetrated 
into cytosolic region. (3) Ir-Es binds to intracellular 
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mitochondria with high membrane potential (Δψm),22 induced 
secondary damage under continued 2P irradiation. 
 
Fig.4 (a) Solid tumour model treated with PBS, Ce6, and Ir-Es, 
the tumours were extracted at 21st day. (b) The growth curve 
and (c) growth inhibition rate of the solid tumour in the mice 
over 21 days under different treatment, the arrow indicated the 
injection (local) time point. 
To further assess the capability of Ir-Es as a potential PDT agent 
in vivo, mouse models were performed. The mice with solid 
tumour planted (n = 6) were treated with Ir-Es and Ir-Me, 
respectively. For comparison, Ce6 a clinical PDT agent was 
applied, PBS and solely irradiation treated (660nm, 1400mA, 
Fig. 4 and Fig. S32) animals were also added as negative control. 
Fig. 4a directly presented the morphology of the tumour from 
mice after 21 days’ treatment. As it measured daily in Fig. 4b, 
the volume of tumour treated with Ir-Me and under irradiation 
(808 nm, 600mA) is not significant difference from that treated 
with PBS. This suggested that although Ir-Me displayed certain 
damage towards cancerous cells in vitro in living cells, its in vivo 
PDT effect was very limited. On the contrary, when treated with 
Ir-Es, the growth of tumour was significantly inhibited (Fig. 4c, 
anti-tumour rate, ATR: 41.58 %) and similar to the outcome of 
the commercial PDT agents Ce6 (ATR: 40.76 %). Predominated 
necrosis and apoptotic regions were also presented in Both H&E 
staining and Tunnel staining tumour tissue sections (Fig. S33) 
from groups treated Ir-Es.  
In summary, we have designed and synthesized series of novel 
Iridium complexes and invested their photophysical properties 
in detail. With slightly modification on terminal substitute, 
these Iridium complexes were rerouted in nucleus (Ir-Es) and 
the mitochondria (Ir-Me, Ir-Pn, Ir-Pc, Ir-Cz), respectively. In 
cellulo studies revealed that Ir-Es complex presented low 
cytotoxicity in dark and displayed high cell damage under light 
irradiation. In particularly, we firstly demonstrated that a 
nuclear targeting complex Ir-Es generated significant ‘double’ 
damage sequentially form nucleus to mitochondria under two-
photon irradiation, then successfully applied as a solid tumour 
growth inhibitor as a PDT agent using two-photon laser power. 
This study not only offers a competitive PDT candidate for 
therapeutic purpose, but also provides an idea on how to 
regulate the intracellular targeting within metallic molecular 
system via minor modification.  
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China (1708085MC68), Anhui University Doctor Startup Fund 
(J01001962). We thank Dr. Martin R Gill (University of Oxford, 
Oxford, Department of Oncology) for useful suggestions and 
help discussions. 
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